- Category
- Micro (2022-23)
- Udyam number
- UDYAM-DL-03-0015048

Vilexo Pharmaceuticals Private Limited
About Vilexo Pharmaceuticals Private Limited
Data last updated:
Vilexo Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 10 February 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2022PTC393662.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Satyendra Sharma Kumar and Vikas Saxena.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 482/1/3 GF Devali Village Near Rajdhani Inc, Delhi, India – 110062.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.37 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹1.81 Lakh (net margin 1.3%) and EBITDA of ₹2.63 Lakh (EBITDA margin 1.9%).
Vilexo Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0015048).
Company details
Recognitions & Rankings of Vilexo Pharmaceuticals
Contact details
Vilexo Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered Address482/1/3 GF Devali Village Near Rajdhani Inc, Delhi, India – 110062
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vilexo Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vilexo Pharmaceuticals Private Limited, buy the company report.
Financials of Vilexo Pharmaceuticals Private Limited
FY 2025 filings availableVilexo Pharmaceuticals Private Limited reported revenue of ₹1.37 Cr (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 7% in the latest year. EBITDA fell 7% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.63 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.81 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.9% | ||
| Net Profit Margin | 1.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Vilexo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vilexo Pharmaceuticals Private Limited
Vilexo Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyendra Sharma Kumar | Director | 10 Feb 2022 | 4 Years 9 Months | Current |
| Vikas Saxena | Director | 24 Dec 2024 | 1 Years 10 Months | Current |
| Arun Sharma | Director | 05 Jan 2026 | 0 Years 10 Months | Current |
Peer comparison
Vilexo Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sierra Pharmaceuticals Limited. | ₹1.38 Cr (FY 2024) | -11.0% | New Delhi, Delhi, India | |||
| Vilexo Pharmaceuticals Private Limitedthis company | ₹1.37 Cr (FY 2024) | ₹1.81 Lakh | 1.3% | 7.0% | Delhi, India | |
| Mencure Pharmaceuticals Private Limited | ₹1.37 Cr (FY 2024) | 12.0% | Patna, Bihar, India | |||
| Criceto Pharmaceuticals Private Limited | ₹1.36 Cr (FY 2025) | 43.0% | Guwahati, Assam, India |
To see the full peer comparison of Vilexo Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vilexo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vilexo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Vilexo Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Vilexo Pharmaceuticals Private Limited has 6 board changes on record since 2022: 5 appointments and 1 cessation. The latest: Arun Sharma was appointed as Director on 05 Jan 2026.
Frequently asked questions
Vilexo Pharmaceuticals is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 10 February 2022 (4+ years old) and is registered under CIN U51909DL2022PTC393662.
Vilexo Pharmaceuticals has 3 current directors:
- Satyendra Sharma Kumar - Director
- Vikas Saxena - Director
- Arun Sharma - Director
The latest financial statements of Vilexo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Vilexo Pharmaceuticals is U51909DL2022PTC393662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vilexo Pharmaceuticals was incorporated on 10 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Vilexo Pharmaceuticals by revenue are Sierra Pharmaceuticals Limited, Mencure Pharmaceuticals Private Limited, Criceto Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Arun Sharma was appointed as Director on 05 Jan 2026. Babita Saxena ceased to be Additional Director on 24 Dec 2024. Vikas Saxena was appointed as Director on 24 Dec 2024. Vilexo Pharmaceuticals has 6 board changes on record in total.
Yes, Vilexo Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0015048).
The registered office of Vilexo Pharmaceuticals is at 48213 GF Devali Village Near Rajdhani Inc, Delhi, India – 110062.
Vilexo Pharmaceuticals operates in the trading industry, in the specialty segment.
Vilexo Pharmaceuticals can be reached at its registered office: 48213 GF Devali Village Near Rajdhani Inc, Delhi, India – 110062.

